 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$0.77 |
$0.78 |
$0.70 |
$0.71 |
440.10K | | 04/16/2024 |
$0.71 |
$0.72 |
$0.63 |
$0.71 |
603.10K | | 04/17/2024 |
$0.71 |
$0.75 |
$0.70 |
$0.73 |
184.60K | | 04/18/2024 |
$0.73 |
$0.74 |
$0.68 |
$0.69 |
363.10K | | 04/19/2024 |
$0.69 |
$0.70 |
$0.65 |
$0.66 |
350.80K |
|
|
| Cara Therapeutics is an early commercial-stage biopharmaceutical company focusing on a new treatment paradigm to improve the lives of patients suffering from pruritus. Co.'s KORSUVA injection is an FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease, in adults undergoing hemodialysis. Co. is developing an Oral KORSUVA (difelikefalin) formulation for the treatment of pruritus in patients with atopic dermatitis, and non-dialysis-dependent chronic kidney disease. Phase 2 trials of Oral KORSUVA (difelikefalin) are ongoing in primary biliary cholangitis, and in notalgia paresthetica patients with moderate-to-severe pruritus. | |
|
Cara Therapeutics (CARA) has the following price history information. Looking back at CARA historical stock prices for the last five trading days, on April 15, 2024, CARA opened at $0.77, traded as high as $0.78 and as low as $0.70, and closed at $0.71. Trading volume was a total of 440.10K shares. On April 16, 2024, CARA opened at $0.71, traded as high as $0.72 and as low as $0.63, and closed at $0.71. Trading volume was a total of 603.10K shares. On April 17, 2024, CARA opened at $0.71, traded as high as $0.75 and as low as $0.70, and closed at $0.73. Trading volume was a total of 184.60K shares. On April 18, 2024, CARA opened at $0.73, traded as high as $0.74 and as low as $0.68, and closed at $0.69. Trading volume was a total of 363.10K shares. On April 19, 2024, CARA opened at $0.69, traded as high as $0.70 and as low as $0.65, and closed at $0.66. Trading volume was a total of 350.80K shares.
CARA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cara Therapeutics shares, starting with a $10,000 purchase of CARA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$16.72 |
|
| End price/share: |
$0.66 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-96.05% |
|
| Average Annual Total Return: |
-27.61% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$395.17 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/15/2024 | $0.71 | | 04/16/2024 | $0.71 | | 04/17/2024 | $0.73 | | 04/18/2024 | $0.69 | | 04/19/2024 | $0.66 |
|
|
Free CARA Email Alerts:
